| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| STAAR SURGICAL CO | General Counsel | Common Stock | 21.9K | $595K | $27.11 | Dec 11, 2023 | Direct |
| STAAR SURGICAL CO | General Counsel | Restricted Stock Units | 17.5K | $474K | $27.11 | Mar 12, 2024 | Direct |
| STAAR SURGICAL CO | General Counsel | Common Stock Options | 15.7K | Mar 12, 2024 | Direct | ||
| NUVASIVE INC | SVP & General Counsel | Common Stock, par value $0.001 per share | 0 | $42.67 | Sep 1, 2023 | Direct | |
| NUVASIVE INC | SVP & General Counsel | Performance Restricted Stock Unit | 0 | Sep 1, 2023 | Direct | ||
| NUVASIVE INC | SVP & General Counsel | Restricted Stock Unit | 0 | Sep 1, 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| STAA | STAAR SURGICAL CO | Mar 12, 2024 | 2 | $0 | 4 | Mar 14, 2024 | General Counsel |
| STAA | STAAR SURGICAL CO | Dec 11, 2023 | 2 | $0 | 4 | Dec 12, 2023 | General Counsel |
| STAA | STAAR SURGICAL CO | Dec 11, 2023 | 0 | $0 | 3 | Dec 12, 2023 | General Counsel |
| NUVA | NUVASIVE INC | Sep 1, 2023 | 6 | $0 | 4 | Sep 5, 2023 | SVP & General Counsel |
| NUVA | NUVASIVE INC | Mar 1, 2023 | 4 | -$84.3K | 4 | Mar 3, 2023 | SVP & General Counsel |
| NUVA | NUVASIVE INC | Mar 1, 2022 | 5 | -$156K | 4 | Mar 3, 2022 | SVP & General Counsel |
| NUVA | NUVASIVE INC | Feb 10, 2022 | 1 | $0 | 4 | Feb 14, 2022 | SVP & General Counsel |